Global Blood Plasma Market Size, Share Report, Analysis, Trends, Growth 2032

Blood Plasma Market

Global Blood Plasma Market Analysis By Distribution Channel (Ambulatory Surgical Centers, Hospitals, And Others), By Application (Coagulation Factor Deficiencies, Hemorrhage, Thrombotic Thrombocytopenic Purpura, Liver Disease, And Other Plasma Applications), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024-2032

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-2959 Published Date: Oct-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 34.02 Billion USD 59.97 Billion 6.50% 2023

 

Blood Plasma Market: Industry Prospective

The global blood plasma market size accrued earnings worth approximately USD 34.02 Billion in 2023 and is predicted to gain revenue of about USD 59.97 Billion by 2032, is set to record a CAGR of nearly 6.50% over the period from 2024 to 2032. The report offers valuation and analysis of Blood Plasma market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data.

Global Blood Plasma Market SizeRequest Free Sample

Blood Plasma Market Overview

Blood plasma is light-yellowish in color or is straw colored and it acts as liquid base for the blood. Apparently, platelets, red blood corpuscles, and leukocytes make up blood plasma. For the record, blood plasma comprise of nearly 91% to 92% of water and about 9% to 8% of solids. Apparently, coagulants present in blood plasma help in clotting of blood. Electrolytes such as sodium, chloride, calcium, and potassium in blood plasma assist in maintaining the blood pH proportion.

Furthermore, plasma proteins of blood plasma assist in retaining the colloidal osmotic pressure at nearly 25 mmHg. In addition to this, immunoglobulin present in blood plasma helps in combating various kinds of infections. Precisely, blood plasma is a composite of over seven-hundred proteins and enables proficient body functioning.

Global Blood Plasma MarketRequest Free Sample

Blood Plasma Market: Growth Drivers

Surge in the occurrence of life-threatening disorders like hemophilia is anticipated to create lucrative growth avenues for the market over the projected timespan. Additionally, rise in the acceptance of blood plasma derived products along with a prominent surge in the aging populace prone to liver disorders will culminate in huge demand for blood plasma in the medical industry over the forecast timespan. Apart from this, a large number of benefits offered by blood plasma like coagulation of blood, defense, nutrition, maintaining of osmotic pressure, respiration, excretion, regulating of acid-base balance, and controlling body temperature has transformed into huge market demand in the current years.

Furthermore, blood plasma helps in controlling blood pressure in the human being. Rise in the health problems as a result of altering lifestyles, increase in the fund allocation to healthcare sector, and growing penetration of plasma-derived items in the healthcare industry will create lucrative growth avenues for the industry over the estimated timeline. Nonetheless, high plasma derivative treatment costs as well as post-operative risks related to plasma replacement treatment will put brakes on the industry growth over the forecast timespan.

Blood Plasma Market: Report Scope

Report Attributes Report Details
Report Name Blood Plasma Market
Market Size in 2023 USD 34.02 Billion
Market Forecast in 2032 USD 59.97 Billion
Growth Rate CAGR of 6.50%
Number of Pages 207
Key Companies Covered Grifols S.A., Kedrion S.p.A., Octopharma AG, Baxter International Inc., CSL Ltd., Biotest AG, Shire, China Biologic Products, and Sanquin.
Segments Covered By Application, By Distribution Channel, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Blood Plasma Market: Regional Insights

North American Market To Witness Mammoth Growth By 2032

The expansion of the industry in the sub-continent over the projected timeline is due to massive patient population base in the countries like the U.S. that is affected due to blood coagulation, hemostasis, and hemorrhage. Additionally, new initiatives introduced by the government for creating awareness about the significance of blood donation will proliferate the regional market expansion in the years ahead. In addition to this, occurrence of chronic disorders like heart ailments and cancer will promote the expansion of blood plasma industry in North America over the assessment timeline.

Blood Plasma Market: Competitive Space

Key participants profiled in the study include

  • Grifols S.A.
  • Kedrion S.p.A.
  • Octopharma AG
  • Baxter International Inc.
  • CSL Ltd.
  • Biotest AG
  • Shire
  • China Biologic Products
  • and Sanquin.

The global blood plasma market is segmented as follows:

By Application

  • Coagulation factor deficiencies
  • Thrombotic thrombocytopenic purpura
  • Hemorrhage
  • Liver disease
  • Other plasma applications

By Distribution Channel

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Surge in the occurrence of life-threatening disorders like hemophilia is anticipated to create lucrative growth avenues for the market over the projected timespan.

According to Zion Market Research report, The global blood plasma market size accrued earnings worth approximately USD 34.02 Billion in 2023 and is predicted to gain revenue of about USD 59.97 Billion by 2032, is set to record a CAGR of nearly 6.50% over the period from 2024 to 2032.

North America is likely to make noteworthy contributions towards overall Blood Plasma Market revenue. 

The key players profiled in the report include Grifols S.A., Kedrion S.p.A., Octopharma AG, Baxter International Inc., CSL Ltd., Biotest AG, Shire, China Biologic Products, and Sanquin.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed